Davenport & Co’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-77,243
| Closed | -$7.14M | – | 781 |
|
|
2019
Q3 | $7.14M | Sell |
77,243
-401
| -0.5% | -$38.1K | 0.09% | 135 |
|
|
2019
Q2 | $7.18M | Sell |
77,644
-7,811
| -9% | -$742K | 0.09% | 132 |
|
|
2019
Q1 | $8.06M | Sell |
85,455
-3,893
| -4% | -$340K | 0.1% | 125 |
|
|
2018
Q4 | $5.73M | Sell |
89,348
-37,856
| -30% | -$2.79M | 0.08% | 145 |
|
|
2018
Q3 | $11.4M | Sell |
127,204
-6,206
| -5% | -$548K | 0.13% | 119 |
|
|
2018
Q2 | $10.6M | Buy |
133,410
+3,245
| +2% | +$269K | 0.13% | 118 |
|
|
2018
Q1 | $11.6M | Sell |
130,165
-470,334
| -78% | -$45.2M | 0.14% | 114 |
|
|
2017
Q4 | $62.7M | Buy |
600,499
+33,294
| +6% | +$3.76M | 0.75% | 38 |
|
|
2017
Q3 | $82.7M | Buy |
567,205
+1,624
| +0.3% | +$221K | 1.05% | 20 |
|
|
2017
Q2 | $73.5M | Buy |
565,581
+14,701
| +3% | +$1.8M | 0.97% | 22 |
|
|
2017
Q1 | $64.5M | Sell |
550,880
-3,262
| -0.6% | -$390K | 0.92% | 25 |
|
|
2016
Q4 | $64.1M | Buy |
554,142
+12,639
| +2% | +$1.41M | 0.92% | 24 |
|
|
2016
Q3 | $56.6M | Sell |
541,503
-2,582
| -0.5% | -$279K | 0.83% | 32 |
|
|
2016
Q2 | $53.7M | Sell |
544,085
-21,776
| -4% | -$2.25M | 0.82% | 35 |
|
|
2016
Q1 | $56.6M | Buy |
565,861
+8,892
| +2% | +$916K | 0.89% | 31 |
|
|
2015
Q4 | $66.7M | Buy |
556,969
+3,471
| +0.6% | +$402K | 1.08% | 25 |
|
|
2015
Q3 | $59.9M | Buy |
553,498
+362
| +0.1% | +$44.9K | 1.01% | 26 |
|
|
2015
Q2 | $64M | Buy |
553,136
+180
| +0% | +$20.6K | 0.99% | 24 |
|
|
2015
Q1 | $63.7M | Sell |
552,956
-103,866
| -16% | -$12.4M | 0.98% | 26 |
|
|
2014
Q4 | $73.5M | Buy |
656,822
+2,681
| +0.4% | +$283K | 1.19% | 15 |
|
|
2014
Q3 | $62M | Buy |
654,141
+5,224
| +0.8% | +$471K | 1.08% | 23 |
|
|
2014
Q2 | $55.7M | Buy |
648,917
+161,369
| +33% | +$12.3M | 0.95% | 29 |
|
|
2014
Q1 | $34M | Sell |
487,548
-17,570
| -3% | -$1.39M | 0.62% | 60 |
|
|
2013
Q4 | $42.7M | Buy |
505,118
+2,340
| +0.5% | +$185K | 0.8% | 42 |
|
|
2013
Q3 | $38.7M | Buy |
502,778
+19,094
| +4% | +$1.34M | 0.8% | 43 |
|
|
2013
Q2 | $28.3M | Buy |
+483,684
| New | +$29.1M | 0.62% | 64 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Davenport & Co's CELG Position: Q4 2019 in Review
Davenport & Co sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 77,243 shares — an estimated $7.14M sold.
Davenport & Co first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $82.7M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Davenport & Co reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Davenport & Co sold 77,243 Celgene Corp shares in Q4 2019, an estimated $7.14M.
- Davenport & Co first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Davenport & Co's Celgene Corp position peaked at $82.7M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Davenport & Co's 13F filing for Q4 2019, filed 22 Jan 2020.